Wantai BioPharm and Jinyuan Xintong Forge Strategic Partnership to Advance High-Quality Development of Medical Laboratories

On October 31, 2025, during the NCLM held in Jinan, China, Wantai BioPharm Co., Ltd. and Shenzhen Jinyuan Xintong officially signed a strategic cooperation agreement. Leveraging Wantai BioPharm’s strong foundation in biological diagnostic reagents and quality control products, and combining it with Jinyuan Xintong’s expertise in laboratory standardization, digitalization, intelligent software, and ISO 15189 accreditation consulting services, the two parties will engage in in-depth collaboration in multiple areas including smart laboratory construction and laboratory quality management. This strategic partnership marks not only a win-win cooperation of complementary strengths but also a significant step toward their shared vision of “Better human health through technological innovation.”

Zybio and Beckman Coulter Announce Strategic Partnership

On October 31, 2025, Zybio Inc. and Beckman Coulter Commercial (China) Co., Ltd. officially signed a strategic cooperation agreement at the NCLM exhibition. This partnership between Zybio and Beckman Coulter represents more than a business collaboration—it reflects a shared commitment to advancing the medical diagnostics industry under the “Healthy China” initiative. Zybio stated that it looks forward to integrating its technological expertise with Beckman Coulter’s global innovation capabilities to inject new vitality into China’s laboratory medicine sector. Beckman Coulter emphasized its long-term commitment to China, advancing its “Created in China” localization strategy. As a key member of our local ecosystem, Zybio will work closely with Beckman Coulter to create shared value, explore new models and frontiers in medical testing, and ultimately benefit patients. The two companies will take this signing as a new starting point to jointly contribute to the high-quality development of laboratory medicine in China and to the health and well-being of people worldwide.

Ping An Good Doctor and KingMed Diagnostics Partner to Advance Medical Data Development

On October 29, during the 2025 Data Element Innovation Application and Ecosystem Development Forum organized by the Guangzhou Data Element Industry Association, KingMed Diagnostics and Ping An Good Doctor signed a cooperation agreement to jointly explore compliant sharing and secure applications of medical data, contributing to the establishment of a unified national data market. This collaboration represents a proactive response to national strategic priorities. The two companies will work together to apply medical data securely, enabling deep data analysis and AI model development across four key clinical scenarios—clinical research, precision diagnosis and treatment, scientific innovation, and public health—while ensuring data security and privacy protection. The partnership will serve as an innovative model for unlocking the value of data elements and advancing their market-based allocation.

“Straits Precision Medicine Center” Established by Xiamen University Zhongshan Hospital and Dian Diagnostics

On November 1, Xiamen University Zhongshan Hospital and Dian Diagnostics jointly announced the establishment of the Straits Precision Medicine Center， which marks a major step forward in Fujian Province’s precision medicine efforts and signifies a regional shift from traditional standardized healthcare toward individualized, precision-based medicine. The center aims to provide advanced, personalized healthcare services tailored to each patient’s needs. Leveraging Zhongshan Hospital’s strong clinical foundation and multidisciplinary expertise, along with Dian Diagnostics’ internationally aligned testing technology platform, high-standard quality control system, and extensive database resources, the center is positioned to become a high-level, exemplary platform integrating clinical services, discipline development, scientific research, and talent cultivation.